These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1627860)

  • 1. Proton MR spectroscopy of gadolinium-enhanced multiple sclerosis plaques.
    Narayana PA; Wolinsky JS; Jackson EF; McCarthy M
    J Magn Reson Imaging; 1992; 2(3):263-70. PubMed ID: 1627860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging.
    Gonzalez-Scarano F; Grossman RI; Galetta S; Atlas SW; Silberberg DH
    Ann Neurol; 1987 Mar; 21(3):300-6. PubMed ID: 3606036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of gadolinium on the sensitivity and specificity of MR in the initial diagnosis of multiple sclerosis.
    Tas MW; Barkhol F; van Walderveen MA; Polman CH; Hommes OR; Valk J
    AJNR Am J Neuroradiol; 1995 Feb; 16(2):259-64. PubMed ID: 7726070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR proton spectroscopy in multiple sclerosis.
    Grossman RI; Lenkinski RE; Ramer KN; Gonzalez-Scarano F; Cohen JA
    AJNR Am J Neuroradiol; 1992; 13(6):1535-43. PubMed ID: 1442428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple sclerosis: serial study of gadolinium-enhanced MR imaging.
    Grossman RI; Braffman BH; Brorson JR; Goldberg HI; Silberberg DH; Gonzalez-Scarano F
    Radiology; 1988 Oct; 169(1):117-22. PubMed ID: 3420246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Axonal damage in multiple sclerosis plaques: a combined magnetic resonance imaging and 1H-magnetic resonance spectroscopy study.
    Simone IL; Tortorella C; Federico F; Liguori M; Lucivero V; Giannini P; Carrara D; Bellacosa A; Livrea P
    J Neurol Sci; 2001 Jan; 182(2):143-50. PubMed ID: 11137520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short echo time proton MR spectroscopic imaging.
    Posse S; Schuknecht B; Smith ME; van Zijl PC; Herschkowitz N; Moonen CT
    J Comput Assist Tomogr; 1993; 17(1):1-14. PubMed ID: 8380426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The evolution of multiple sclerosis lesions on serial MR.
    Guttmann CR; Ahn SS; Hsu L; Kikinis R; Jolesz FA
    AJNR Am J Neuroradiol; 1995 Aug; 16(7):1481-91. PubMed ID: 7484637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serial study of gadolinium-DTPA MRI enhancement in multiple sclerosis.
    Bastianello S; Pozzilli C; Bernardi S; Bozzao L; Fantozzi LM; Buttinelli C; Fieschi C
    Neurology; 1990 Apr; 40(4):591-5. PubMed ID: 2320230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis of renal artery stenosis: feasibility of combining MR angiography, MR renography, and gadopentetate-based measurements of glomerular filtration rate.
    Ros PR; Gauger J; Stoupis C; Burton SS; Mao J; Wilcox C; Rosenberg EB; Briggs RW
    AJR Am J Roentgenol; 1995 Dec; 165(6):1447-51. PubMed ID: 7484583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serial proton magnetic resonance spectroscopy in acute multiple sclerosis lesions.
    Davie CA; Hawkins CP; Barker GJ; Brennan A; Tofts PS; Miller DH; McDonald WI
    Brain; 1994 Feb; 117 ( Pt 1)():49-58. PubMed ID: 8149214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inadvertent i.v. administration of gadopentetate dimeglumine during early pregnancy.
    Barkhof F; Heijboer RJ; Algra PR
    AJR Am J Roentgenol; 1992 May; 158(5):1171. PubMed ID: 1566688
    [No Abstract]   [Full Text] [Related]  

  • 13. In vivo characterization of the multiple sclerosis plaque by magnetic resonance imaging and spectroscopy.
    Larsson HB
    Acta Neurol Scand Suppl; 1995; 159():1-44. PubMed ID: 7625161
    [No Abstract]   [Full Text] [Related]  

  • 14. Multiple sclerosis: gadolinium enhancement in MR imaging.
    Grossman RI; Gonzalez-Scarano F; Atlas SW; Galetta S; Silberberg DH
    Radiology; 1986 Dec; 161(3):721-5. PubMed ID: 3786722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton MRS of gadolinium-enhancing MS plaques and metabolic changes in normal-appearing white matter.
    Roser W; Hagberg G; Mader I; Brunnschweiler H; Radue EW; Seelig J; Kappos L
    Magn Reson Med; 1995 Jun; 33(6):811-7. PubMed ID: 7651118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Routine use of gadopentetate dimeglumine in cranial MR imaging of patients with AIDS.
    Elster AD
    AJR Am J Roentgenol; 1993 Sep; 161(3):680-1. PubMed ID: 8352135
    [No Abstract]   [Full Text] [Related]  

  • 17. Gadopentetate dimeglumine-enhanced MR imaging of subdural hematoma in an abused infant.
    Kleinman PK; Ragland RL
    AJR Am J Roentgenol; 1996 Jun; 166(6):1456-8. PubMed ID: 8633463
    [No Abstract]   [Full Text] [Related]  

  • 18. Acute transverse myelopathy: spinal and cranial MR study with clinical follow-up.
    Campi A; Filippi M; Comi G; Martinelli V; Baratti C; Rovaris M; Scotti G
    AJNR Am J Neuroradiol; 1995 Jan; 16(1):115-23. PubMed ID: 7900579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of magnetic resonance imaging sensitivity in patients with relapsing remitting multiple sclerosis: baseline versus Betaseron treatment trials.
    Frank JA; Bash C; Stone L; Petrella J; Maloni H; McFarland H
    Acad Radiol; 1996 Aug; 3 Suppl 2():S173-5. PubMed ID: 8796554
    [No Abstract]   [Full Text] [Related]  

  • 20. MR imaging of the brain in patients with AIDS: value of routine use of i.v. gadopentetate dimeglumine.
    Jensen MC; Brant-Zawadzki M
    AJR Am J Roentgenol; 1993 Jan; 160(1):153-7. PubMed ID: 8416615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.